IPO Comments to European Commission On EU Compulsory Licensing Proposal
IPO Comments to European Commission On EU Compulsory Licensing Proposal
IPO Comments to USPTO Regarding Motion To Amend Pilot Program and Rules of Practice To Allocate the Burdens of Persuasion on Motions To Amend in Trial Proceedings Before the PTAB
IPO Comments to USPTO Regarding Motion To Amend Pilot Program [...]
IPO Comments to USPTO Regarding Advance Notice of Proposed Rulemaking on PTAB Discretionary Institution Practices
IPO Comments to USPTO Regarding Advance Notice of Proposed Rulemaking [...]
IPO Comments Regarding USPTO Proposed Trademark Fee Schedule
IPO Comments Regarding USPTO Proposed Trademark Fee Schedule
IPO Comments to Patent Public Advisory Committee re: USPTO Proposed Patent Fee Adjustments
IPO Comments to Patent Public Advisory Committee re: USPTO Proposed [...]
IPO Comments to USPTO Regarding Artificial Intelligence and Inventorship
IPO Comments to USPTO Regarding Artificial Intelligence and Inventorship
IPO Comments to FTC Regarding Non-Compete Clause Rule, Matter No. P201200
IPO Comments to FTC Regarding Non-Compete Clause Rule, Matter No. [...]
IPO Comments on the Updated EPO Guidelines for Examination
IPO Comments on the Updated EPO Guidelines for Examination
IPO Testimony to U.S. ITC Regarding COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
IPO Testimony to U.S. ITC Regarding COVID-19 Diagnostics and Therapeutics: [...]
IPO Response to Questions Re: USTR 2023 Special 301 Review
IPO Response to Questions Re: USTR 2023 Special 301 Review
Posts tagged here will show on the testimony and comments page.